29-Apr-2004 - Waters Corporation

Vertex Pharmaceuticals Selects Waters NuGenesis Scientific Data Management Solution

Waters announced that Vertex Pharmaceuticals Inc. has selected the Waters® NuGenesis® Scientific Data Management System (SDMS) to support the company's Electronic Lab Notebook (ELN) initiative. Vertex Pharmaceuticals is currently deploying discipline-specific, process-driven Electronic Lab Notebooks throughout its global research organization, with a goal of developing a scalable and universal process for increasing the efficiency of data capture and analysis in research.

"Vertex has developed proprietary Electronic Lab Notebooks for incorporation into our drug discovery research." said Steve Schmidt, Vertex Vice President of Information Systems "Laboratory data management and data archive are essential to this ELN initiative, and we believe the NuGenesis SDMS is the most attractive option to meet this critical need."

"With NuGenesis SDMS, Waters is providing a data management solution for Vertex's novel ELN that will enable streamlined data capture, cataloging, viewing and reuse functions" says Dr. Rohit Khanna, Vice President - Worldwide Marketing for the Waters Division of Waters Corporation. "Scientists and management will also have secure on-line access to project and program progress and a 21 CFR Part 11 compliant data management platform. The NuGenesis SDMS will help Vertex to effectively manage their data today and also help them transition to a more productive, fully-paperless environment."

The Vertex® ELN Initiative

Vertex seeks to discover, develop and commercialize novel, small-molecule drugs that address significant markets with major unmet medical needs. Vertex's Electronic Lab Notebooks are designed to provide easy access to source data and scientists' annotations, which can be integrated with the Company's proprietary research informatics system thus significantly reducing the time spent manually moving data from instrument reports into paper notebooks. Modules for medicinal chemistry and parallel synthesis were deployed in 2003. Vertex plans to deploy additional modules for singleton medicinal chemistry, biology, pharmacology, and formulations by the end of 2004. All of these discipline-specific ELN's will incorporate Waters NuGenesis SDMS software.

Facts, background information, dossiers
  • Vertex Pharmaceuticals
  • medicinal chemistry
  • solution
More about Waters
  • News

    Waters Corporation Appoints Dan Brennan and Mark Vergnano to Board of Directors

    Waters Corporation announced the appointment of Dan Brennan and Mark Vergnano, to its Board of Directors, effective November 23, 2022. Mr. Brennan currently serves as Executive Vice President and Chief Financial Officer of Boston Scientific Corporation, a global medical device company, and ... more

    Waters Appoints John M. Ballbach to Board of Directors

    Waters Corporation announced the appointment of John M. Ballbach to its Board of Directors, effective October 5, 2021. Mr. Ballbach currently serves on the Board of RPM International, Inc., a leader in specialty coatings, sealants, building materials and related services. Waters also announ ... more

    Waters Corporation Appoints Pearl S. Huang to Board of Directors

    Waters Corporation announced that Dr. Pearl S. Huang, President and CEO of Cygnal Therapeutics and venture partner at Flagship Pioneering, has been appointed as a Director of Waters Corporation, effective January 1, 2021.  “We are pleased to welcome Pearl to the Waters Board of Directors,” ... more

  • Products

    A new Tandem Quadrupole Mass Spectrometer for Quantification with Absolute power

    Achieve lower limits of quantitation to meet regulatory requirements ✓ Ensure consistent robustness and reproducibility so you can maintain performance and productivity ✓ Achieve improved environmental sustainability and lower your laboratory operational costs ✓ more

  • White papers

    Detection of Per- and Polyfluorinated Alkyl Substances (PFAS) in Environmental Water Samples

    Application brief to demonstrate improved sensitivity for detection of per- and polyfluorinated alkyl substances in environmental water samples more

  • Companies

    Waters GmbH

    Waters Corporation is a global leader in liquid chromatography (UPLC/HPLC), mass spectrometry (MS), rheology and thermal analysis. The business areas range from research & development, the manufacture and sale of analytical instruments, laboratory software products, column and sample prepar ... more

    Waters SpA

    Since 1958, Waters has offered total solutions in High Performance Liquid Chromatography (HPLC). With our products and services we set the standards in HPLC. Waters Corporation is a multinational, publicly traded (NYSE: WAT) company headquartered in Milford, Massachusetts, USA. The company ... more

    Waters GmbH

    Waters Corporation creates business advantage for laboratory-dependent organizations by delivering practical and sustainable innovation to enable significant advancements in such areas as healthcare delivery, environmental management, food safety, and water quality worldwide. Pioneering a c ... more